NINDS Open House

Monday, February 25, 2019
9:00 am – 4:00 pm
Guest Speaker: Dr. Amir Tamiz, Ph.D.
College of Pharmacy – L.S. Skaggs Pharmacy Institute, Auditorium

Since 1975, the University of Utah has been the primary contract site for the NINDS-­‐funded Anticonvulsant Screening Program (ASP; now ETSP), to perform preclinical studies to identify new treatments for epilepsy. Current efforts are focused on identifying treatments to address unmet needs in epilepsy, including pharmacoresistant epilepsy, comorbidities, and disease prevention/modification.

Please join Karen Wilcox, Ph.D. (Principal Investigator) and other contract site staff in an open house of their testing facilities on February 25, 2019, in the College of Pharmacy – L.S. Skaggs Pharmacy Institute, Skaggs Pharmacy Auditorium.

The morning session will also include a presentation from Dr. Amir Tamiz, Director of Division of Translational Research at the National Institute of Neurological Disorders and Stroke (NINDS), NIH. Dr. Tamiz will speak on funding opportunities at the NINDS Office of translational research, including HEAL initiative opportunities. 

 

Blog Search